Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Giacomo Casabona, Olivia Berton, Tina Singh, Markus Knuf & Paolo Bonanni. (2023) Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context. Expert Review of Vaccines 22:1, pages 764-776.
Read now
Read now
Florence Kauffmann, Angela Bechini, Paolo Bonanni, Giacomo Casabona & Peter Wutzler. (2020) Varicella vaccination in Italy and Germany – different routes to success: a systematic review. Expert Review of Vaccines 19:9, pages 843-869.
Read now
Read now
Pasquale Stefanizzi, Sara De Nitto, Francesco Patano, Francesco Paolo Bianchi, Davide Ferorelli, Paolo Stella, Domenica Ancona, Vito Bavaro & Silvio Tafuri. (2020) Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017. Human Vaccines & Immunotherapeutics 16:8, pages 1875-1883.
Read now
Read now
Alberto Donzelli, Alessandro Schivalocchi & Giulia Giudicatti. (2018) Non-specific effects of vaccinations in high-income settings: How to address the issue?. Human Vaccines & Immunotherapeutics 14:12, pages 2904-2910.
Read now
Read now
Articles from other publishers (7)
F. Moretti, L. Gonella, S. Gironi, A. R. Marra, C. Santuccio, P. Felicetti, F. Petronzelli, P. Marchione, S. A. Barnaba, A. Poli, G. Zanoni & U. Moretti. (2020) Ten years of vaccinovigilance in Italy: an overview of the pharmacovigilance data from 2008 to 2017. Scientific Reports 10:1.
Crossref
Crossref
Gabriele Anichini, Claudia Gandolfo, Simonetta Fabrizi, Giovan Battista Miceli, Chiara Terrosi, Gianni Gori Savellini, Shibily Prathyumnan, Daniela Orsi, Giuseppe Battista & Maria Grazia Cusi. (2020) Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy. Vaccines 8:1, pages 66.
Crossref
Crossref
Paolo Bellavite & Alberto Donzelli. (2021) Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data. F1000Research 9, pages 1176.
Crossref
Crossref
Paolo Bellavite & Alberto Donzelli. (2020) Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data. F1000Research 9, pages 1176.
Crossref
Crossref
Stefanizzi, Stella, Ancona, Malcangi, Bianchi, De Nitto, Ferorelli, Germinario & Tafuri. (2019) Adverse Events Following Measles-Mumps-Rubella-Varicella Vaccination and the Case of Seizures: A Post Marketing Active Surveillance in Puglia Italian Region, 2017–2018. Vaccines 7:4, pages 140.
Crossref
Crossref
Meredith Woodward, Ann Marko, Susan Galea, Barry Eagel & Walter Straus. (2019) Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data. Open Forum Infectious Diseases 6:8.
Crossref
Crossref
Paolo Durando, Susanna Esposito, Gianni Bona, Mario Cuccia, Maria Giuseppina Desole, Giuseppe Ferrera, Giovanni Gabutti, Angelo Pellegrino, Filippo Salvini, Ouzama Henry, Michael Povey & Federico Marchetti. (2016) The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy. Vaccine 34:36, pages 4278-4284.
Crossref
Crossref